Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 19 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

21%

4 trials in Phase 3/4

Results Transparency

44%

7 of 16 completed trials have results

Key Signals

1 recruiting7 with results

Enrollment Performance

Analytics

N/A

6(60.0%)

Phase 3

4(40.0%)

10Total

N/A(6)

Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials

NCT01842568Completed

Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery

Role: collaborator

NCT03214029Active Not Recruiting

COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial

Role: collaborator

NCT05322395Not ApplicableRecruiting

Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway

Role: collaborator

NCT03047603Completed

Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC

Role: collaborator

NCT01291836Completed

Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study

Role: collaborator

NCT02060760Completed

Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes

Role: collaborator

NCT01852123Not ApplicableCompleted

High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome

Role: collaborator

NCT02706574Unknown

Brain Injury Assessment Study at Hennepin County Medical Center

Role: collaborator

NCT03285295Not ApplicableCompleted

Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol

Role: lead

NCT02262286Completed

MIND (Management of Traumatic Brain Injury Diagnosis)

Role: lead

NCT01292317Not ApplicableCompleted

Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Nephropathy

Role: collaborator

NCT01746407Completed

Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis

Role: lead

NCT01608100Phase 3Completed

Evaluation of a New Cardiac Biomarker Assay

Role: lead

NCT00979979Completed

Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test

Role: collaborator

NCT01662362Not ApplicableCompleted

Abbott ESA Chagas Assay Post-Market Study

Role: lead

NCT00718042Not ApplicableCompleted

Evaluation of Chagas Blood Screening and Confirmatory Assays

Role: lead

NCT00686205Phase 3Completed

Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay

Role: lead

NCT00933933Phase 3Completed

Evaluation of Diagnostic HIV Ag/Ab Combo Assay

Role: lead

NCT00032435Phase 3Completed

Homocysteine Study (HOST)

Role: collaborator

All 19 trials loaded